ADA Action Center
Welcome to the ADA Action Center, designed to bring you the latest updates from the American Diabetes Association’s (ADA) Scientific Sessions. This collection features the latest scientific advances, groundbreaking research presentations, and expert insights on clinical diabetes and therapeutics, acute and chronic diabetic complications, and more.
1-12 of 12
Survodutide in Obesity: Insights from SYNCHRONIZE-1
Diabetes DiscourseSurvodutide in Obesity: Insights from SYNCHRONIZE-1
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
Addressing Cost-Related Medication Non-Adherence in Diabetes
Diabetes DiscourseAddressing Cost-Related Medication Non-Adherence in Diabetes
Kimberly Narain, MD, MPH, PhD
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes DiscourseUnderstanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
Digital Innovation in Diabetes Prevention for Older Adults
Diabetes DiscourseDigital Innovation in Diabetes Prevention for Older Adults
Steve Jackson, PharmD
Souptik Barua, PhD
Emily Johnston, MPH, PhD
Incretin-Based Advances in Obesity and T2D Care
Diabetes DiscourseIncretin-Based Advances in Obesity and T2D Care
Javier Morales, MD, FACP, FACE
Addressing Unmet Needs in Type 1 Diabetes Management
Diabetes DiscourseAddressing Unmet Needs in Type 1 Diabetes Management
Javier Morales, MD, FACP, FACE
- advertisement
Highlights from the Final Days of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterHighlights from the Final Days of the American Diabetes Association's 82nd Scientific Sessions
Highlights From Day 3 of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterHighlights From Day 3 of the American Diabetes Association's 82nd Scientific Sessions
Tirzepatides & Therapeutic Inertia: Highlights from ADA
ADA Action CenterTirzepatides & Therapeutic Inertia: Highlights from ADA
Carol Wysham, MD
Updates From Day 2 of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterUpdates From Day 2 of the American Diabetes Association's 82nd Scientific Sessions
Recapping Day 1 of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterRecapping Day 1 of the American Diabetes Association's 82nd Scientific Sessions
A Review of Emerging Developments & Updated Guidelines on Hyperglycemia Management
ADA Action CenterA Review of Emerging Developments & Updated Guidelines on Hyperglycemia Management
John Buse, MD, PhD
- advertisement
